Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lenalidomide
B-Cell Neoplasm
M.D. Anderson Cancer CenterP2B (60)
Lenalidomide
Myelodysplastic Syndrome With Excess Blasts
National Cancer Institute (NCI)P2B (60)
Lenalidomide
Plasmacytoma
Memorial Sloan Kettering Cancer CenterP2B (60)
Lenalidomide
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
David Bond, MDP2B (60)
Lenvatinib
Cancer
LaNova Medicines LimitedP2B (60)
Lenvatinib
Pancreatic Neoplasm
Medical College of WisconsinP2B (60)
Lenvatinib
Refractory Malignant Neoplasm
Tongji HospitalP2B (60)
Lenvatinib
Malignant Pancreatic Neoplasm
Du JuanP2B (60)
Lenvatinib
Triple-Negative Breast Carcinoma
Fudan UniversityP2B (60)
Letrozole
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2B (60)
Letrozole
Prostate Carcinoma
Case Comprehensive Cancer CenterP2B (60)
Letrozole
Sarcoma
OHSU Knight Cancer InstituteP2B (60)
Letrozole
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP2B (60)
Letrozole
Triple-Negative Breast Carcinoma
NiKang Therapeutics, Inc.P2B (60)
L-Kappa-H-Gamma1 (Knob) Chain Anti-Dll3 (1-705) [L-Kappa Anti-Dll3 (1-214) [V-Kappa (Homo Sapiens Igkv1-17*03 (94.9%) -Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1-107) -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')] -38-Mer (Ggggse Gkssgsgses Kstegkssgs Gseskstggggs) Linker (215-252) -H-Gamma-1 Heavy Chain Anti-Dll3 (253-705) [Vh (Homo Sapiens Ighv1-46*01 (92.9%) -(Ighd) -Ighj6*01 (94.7%), Cdr-Imgt [8.8.17] (278-285.303-310.349-365)) (253-376)-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V32 Ch3 W22 (Knob) (Ch1 R120 (473) (377-474), Hinge 1-15 (475-489), Ch2 L1.3>A (493), L1.2>A (494) (490-599), Ch3 E12 (615), M14 (617), T22>W (625) (600-704), Chs K2>Del (705)) (377-705)]]; L-Lambda6-H-Gamma1 (Hole) Chain Anti-Cd3E (1-707) [L-Lambda6 Anti-Cd3 (1'-215') [V-Lambda Musmus/Homsap (Mus Musculus Iglv1*01 (82.3%) -Iglj1*01 (100%)/Homo Sapiens Iglv7-46*01 (76.8%) -Iglj3*02 (100%), Cdr-Imgt [9.3.9] (26'-34'.52'-54'.91'-99')) (1'-109') -Homo Sapiens Iglc6*01 (100%) (110'-215')] -38-Mer (Ggggse Gkssgsgses Kstegkssgsgseskstggggs) Linker (216'-253') -H-Gamma-1 Anti-Cd3E (254'-707') [Vh Musmus/Homsap (Mus Musculus Ighv10-1*02 (92.9%) -(Ighd) -Ighj3*01 (100%)/Homo Sapiens Ighv3-73*01 (87.0%) -(Ighd) -Ighj6*01 (81.8%) T123>L (373'), S128>A (378'), Cdr-Imgt [8.10.16] (279'-286'.304'-313'.352'-367')) (254'-378')-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V33 Ch3 S22, A24, V86 (Hole), G1V83 Ch3 R115, F116 (Ch1 R120 (475') (379'-476'), Hinge 1-15 (477'-491'), Ch2 L1.3>A (495'), L1.2>A (496') (492'-601'), Ch3 E12 (617'), M14 (619'), T22>S (627'), L24>A (629'), Y86>V (686'), H115>R (696'), Y116>F (697') (602'-706'), Chs K2>Del (707')) (379'-707')]]; Dimer (485-487':488-490')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Neuroendocrine Neoplasm
Boehringer IngelheimP2B (60)
Losartan
Pancreatic Adenocarcinoma
Colin D. Weekes, M.D., PhDP2B (60)
Losartan
Radiation-Induced Disorder
Massachusetts General HospitalP2B (60)
lp-168
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Zulfa OmerP2B (60)
ltc004
Colorectal Cancer
LetolabP2B (60)
Lurbinectedin
Neuroendocrine Carcinoma
Jazz PharmaceuticalsP2B (60)
lv232
Major Depressive Disorder
Vigonvita Life SciencesP2B (60)
Marble Dust
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP2B (60)
Marcaine
Pancreatic Neoplasm
Masonic Cancer Center, University of MinnesotaP2B (60)
Melphalan
Hematologic Disorder
Baptist Health South FloridaP2B (60)
Melphalan
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer CenterP2B (60)
Showing 1901 to 1925 of 13,155 assets
PreviousPage 77 of 527Next